Archives

Arrowhead Pharmaceuticals is licensing one of its drug candidates, a hepatitis B treatment, to a subsidiary of pharmaceutical giant Johnson

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-OnlineSecurityPrize-2017Pillar: Industrial LeadershipOpening Date: Deadline: Thu, 27 Sep 2018 17:00:00 (Brussels local time)Modification Date: Thu, 4 Oct

In just a few short weeks, BIO will host its annual Patient and Health Advocacy Summit which brings together patient

Karim Dabbagh has been appointed president and CEO of microbiome drug developer Second Genome. Dabbagh is also joining the South

BIO’s member companies in the pharmaceutical, life sciences, chemicals, and biotechnology sectors routinely and strategically outsource their research needs, driven

Novoheart (TSXV: NVH) has appointed Bernard Fermini to serve as chief research and development officer of the Vancouver, BC, stem

[Source: Research & Innovation] The Arctic Circle is the largest network of international dialogue and cooperation on the future of

Over the past two years, I lost both my father and my brother to cancer. I know that my situation

Aoife Brennan has been appointed president and CEO of synthetic biology company Synlogic (NASDAQ: SYBX), effective immediately, the company announced

When Facebook announced last Friday that 50 million user accounts had been compromised, many of us weren’t sure what to